| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1,250 | 0.5% | $206.15 | +$257,688 |
| Sells | 6 | -260,390 | 99.5% | $177.07 | -$46,107,532 |
| Net | -5 | -259,140 | -99% | -$45,849,844 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alex Gorsky | Director | $132,153,735 | 17 Jan 2023 | ||
| Joaquin Duato | CEO and Chairman of the Board, Director | $73,726,789 | -$22,548,655 | -23.4% | 22 Aug 2025 |
| Jennifer L. Taubert | EVP, WWC. Innovative Medicine | $32,516,694 | -$10,040,883 | -23.6% | 04 Sep 2025 |
| Michael H. Ullmann | Exec VP, General Counsel | $31,906,242 | 14 Feb 2022 | ||
| Peter Fasolo | Exec VP, Chief HR Officer | $21,756,253 | 15 Feb 2024 | ||
| Kathryn E. Wengel | EVP, Chief TO and Risk Officer | $18,500,577 | 15 Feb 2025 | ||
| Thibaut Mongon | Exec VP, WW Chair, Cons Health | $15,974,106 | 13 Feb 2023 | ||
| Joseph J. Wolk | Exec VP, CFO | $15,288,576 | -$4,978,449 | -24.6% | 15 Aug 2025 |
| Mathai Mammen | EVP, Pharm, R&D | $10,751,687 | 14 Feb 2022 | ||
| REED JOHN C | EVP, Innovative Medicine, R&D | $9,779,148 | -$7,315,623 | -42.8% | 17 Oct 2025 |
| William Hait | EVP, Chief EI and Med Officer | $9,578,502 | 15 Feb 2024 | ||
| Ashley McEvoy | EVP, WW Chair, MedTech | $9,484,760 | 23 Aug 2023 | ||
| Timothy Schmid | EVP, WW Chair, MedTech | $8,435,710 | -$62,928 | -0.74% | 15 Feb 2025 |
| James Swanson | Evp, Cio | $6,968,548 | 15 Feb 2025 | ||
| Vanessa Broadhurst | EVP, Global Corp Affairs | $6,498,840 | 15 Feb 2025 | ||
| Kristen Mulholland | EVP, Chief HR Officer | $5,278,724 | 15 Feb 2025 | ||
| A. Eugene Washington | Director | $4,542,828 | 07 Mar 2023 | ||
| RONALD A. WILLIAMS | Director | $4,082,264 | 15 Feb 2022 | ||
| CHARLES PRINCE | Director | $3,947,229 | 15 Feb 2022 | ||
| Robert J. Decker | VP Corporate Controller | $3,769,711 | -$1,160,994 | -23.5% | 25 Feb 2025 |
| ANNE M. MULCAHY | Director | $3,481,675 | 25 Apr 2024 | ||
| Mark B. McClellan | Director | $2,897,429 | 24 Apr 2025 | ||
| MARILLYN A. HEWSON | Director | $2,860,628 | 09 Dec 2025 | ||
| Ian Davis | Director | $2,815,437 | 15 Feb 2022 | ||
| Elizabeth Forminard | Executive VP, General Counsel | $2,775,513 | 29 Aug 2025 | ||
| D. SCOTT DAVIS | Director | $2,589,274 | 25 Apr 2024 | ||
| Mary C. Beckerle | Director | $2,212,351 | 24 Apr 2025 | ||
| MARK A. WEINBERGER | Director | $1,627,636 | 24 Apr 2025 | ||
| Jennifer A. Doudna | Director | $1,310,518 | 24 Apr 2025 | ||
| Eugene A. Woods | Director | $1,058,719 | 09 Dec 2025 | ||
| Hubert Joly | Director | $1,048,226 | 24 Apr 2025 | ||
| Nadja West | Director | $825,991 | 24 Apr 2025 | ||
| Darius Adamczyk | Director | $602,052 | 25 Apr 2024 | ||
| Paula A. Johnson | Director | $463,542 | 24 Apr 2025 | ||
| JOHN MORIKIS | Director | $381,070 | +$257,688 | +2.1% | 26 Nov 2025 |
| Daniel E. Pinto | Director | $66,948 | 09 Dec 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|